EVI1 was reported to be overexpressed in 53% of human colorectal cancer samples, 100% of colon adenocarcinoma samples, 100% of human colon cancer cell lines and hence its presence might affect disease progression and sensitivity to chemotherapy6. The gene discussed is MECOM; the disease is colonic neoplasm.